Literature DB >> 19485951

White matter diffusion is higher in Binswanger disease than in idiopathic normal pressure hydrocephalus.

M Tullberg1, D Ziegelitz, S Ribbelin, S Ekholm.   

Abstract

OBJECTIVES: To explore diagnostic differences in periventricular white matter (PWM) and deep white matter (DWM) diffusion patterns in patients diagnosed with Binswanger disease (BD) and in patients diagnosed with probable idiopathic normal pressure hydrocephalus (INPH) using diffusion-weighted imaging (DWI).
MATERIALS AND METHODS: Apparent diffusion coefficient (ADC) values were calculated in the PWM and DWM in patients with INPH (n = 14) and BD (n = 9) and in controls (n = 10) using an spin echo echo planar imaging single-shot diffusion sequence and region of interest (ROI) analysis.
RESULTS: Patients with BD had higher ADC values than patients with INPH in the PWM and DWM in the frontal and occipital regions (P < 0.05) and higher values than controls in the frontal PWM and DWM (P < 0.01). After shunt surgery, ADC values were reduced in the frontal PWM in patients with INPH (P < 0.05).
CONCLUSIONS: Increased diffusion in the PWM and DWM in patients with BD may reflect irreversible breakdown of axonal integrity caused by the subcortical ischaemic vascular disease. By contrast, the normal white matter diffusion in patients with INPH indicates structurally intact axons, compatible with the reversibility of this disorder. DWI may be an important non-invasive diagnostic tool for differentiating between INPH and BD and identifying shunt responders and reversible brain damage in patients with INPH. However, the overlap between patients with INPH and BD in this study restricts the predictive value of the method. (c) 2009 The Authors Journal compilation (c) 2009 Blackwell Munksgaard.

Entities:  

Mesh:

Year:  2009        PMID: 19485951     DOI: 10.1111/j.1600-0404.2009.01165.x

Source DB:  PubMed          Journal:  Acta Neurol Scand        ISSN: 0001-6314            Impact factor:   3.209


  5 in total

1.  The essence of the Japan Radiological Society/Japanese College of Radiology Imaging Guideline.

Authors:  Yasuyuki Yamashita; Sadayuki Murayama; Masahiro Okada; Yoshiyuki Watanabe; Masako Kataoka; Yasushi Kaji; Keiko Imamura; Yasuo Takehara; Hiromitsu Hayashi; Kazuko Ohno; Kazuo Awai; Toshinori Hirai; Kazuyuki Kojima; Shuji Sakai; Naofumi Matsunaga; Takamichi Murakami; Kengo Yoshimitsu; Toshifumi Gabata; Kenji Matsuzaki; Eriko Tohno; Yasuhiro Kawahara; Takeo Nakayama; Shuichi Monzawa; Satoru Takahashi
Journal:  Jpn J Radiol       Date:  2016-01       Impact factor: 2.374

2.  Absence of Disproportionately Enlarged Subarachnoid Space Hydrocephalus, a Sharp Callosal Angle, or Other Morphologic MRI Markers Should Not Be Used to Exclude Patients with Idiopathic Normal Pressure Hydrocephalus from Shunt Surgery.

Authors:  S Agerskov; M Wallin; P Hellström; D Ziegelitz; C Wikkelsö; M Tullberg
Journal:  AJNR Am J Neuroradiol       Date:  2018-12-06       Impact factor: 3.825

3.  Lumbar and ventricular CSF concentrations of extracellular matrix proteins before and after shunt surgery in idiopathic normal pressure hydrocephalus.

Authors:  Karolina Minta; Anna Jeppsson; Gunnar Brinkmalm; Erik Portelius; Henrik Zetterberg; Kaj Blennow; Mats Tullberg; Ulf Andreasson
Journal:  Fluids Barriers CNS       Date:  2021-05-13

4.  MRI diffusion and perfusion alterations in the mesencephalon and pons as markers of disease and symptom reversibility in idiopathic normal pressure hydrocephalus.

Authors:  Simon Agerskov; Jonathan Arvidsson; Doerthe Ziegelitz; Kerstin Lagerstrand; Göran Starck; Isabella M Björkman-Burtscher; Carsten Wikkelsö; Mats Tullberg
Journal:  PLoS One       Date:  2020-10-08       Impact factor: 3.240

5.  Shared CSF Biomarker Profile in Idiopathic Normal Pressure Hydrocephalus and Subcortical Small Vessel Disease.

Authors:  Anna Jeppsson; Maria Bjerke; Per Hellström; Kaj Blennow; Henrik Zetterberg; Petronella Kettunen; Carsten Wikkelsø; Anders Wallin; Mats Tullberg
Journal:  Front Neurol       Date:  2022-03-03       Impact factor: 4.003

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.